SARS-CoV-2 Antigen Rapid Qualitative Test Type B

SARS-CoV-2 Antigen Rapid Qualitative Test Type A

hs-cTnT Rapid Quantitative Test (Chemiluminescence Immunoassay)

hs-cTnT Rapid Quantitative Test (Chemiluminescence Immunoassay) is used for in vitro quantitative detection of the high sensitivity cardiac isoform of TnT (hs-cTnT) concentration in human serum, plasma that contains heparin /EDTA and other anticoagulants and venous whole blood samples, mainly used for auxiliary diagnosis of cardiac diseases.

FLI-600 FIA Immunoassay Analyzer

FLI-600 is a fluorescent immunoassay system with 6 channels that uses blood and urine to measure the quantitative concentration of targeted analyte. Its automated test process enables to carry out multiple simultaneous tests for six different samples.

FT4 Rapid Quantitative Test (Chemiluminescence Immunoassay)

FT4 Rapid Quantitative Test (Chemiluminescence Immunoassay) is used for in vitro quantitative detection of the Free thyroxine 4 (FT4) concentration in human serum, plasma that contains heparin /EDTA and other anticoagulants and venous whole blood samples, mainly used for auxiliary diagnosis of thyroid diseases.

PGI/PGII Rapid Quantitative Test

Human pepsinogens I (PGI) and II (PGII) are proenzymes of pepsin—an endoproteinase of gastric juice. PGI is secreted mainly by chief cells in the fundic mucosa, whereas PGII is also secreted by the pyloric glands and the proximal duodenal mucosa. Serum PGI and PGII concentrations and the ratio between PGI and PGII may be related to the histologic and functional status of the gastric mucosa.

ST2 Rapid Quantitative Test

ST2 is a member of the interleukin-1 receptor family biomarker and circulating soluble ST2 concentrations are believed to reflect cardiovascular stress and fibrosis. The studies have demonstrated soluble ST2 to be a strong predictor of cardiovascular outcomes in both chronic and acute heart failure. It is a new biomarker that meets all required criteria for a useful biomarker.

FLI-100 FIA Analyzer

The ALL NEW FLI-100 Analyser represents an elevated standard at Biotime, in pursuing simplicity, quality assurance, and data security for healthcare organizations. Designed for quantitative in vitro assay determinations, the Biotime FLI-100 analyser was purposefully built to support immunoassay analysis for a broad range of applications – from biomarker work to infectious disease testing. The analyser’s immunofluorescence technology yields high sensitivity, reliable, and reproducible results for convenient point-of-care diagnostic testing on one device with a small footprint.

Detection Kit for Monkeypox Virus ( Real-time PCR )

Detection Kit for Monkeypox Virus ( Real-time PCR ) is designed for the qualitative detection of Monkeypox Virus (MPV) DNA extracted from skin, fluid, or crusts collected directly from skin lesions. It's based on real-time PCR technology, the primers and probes target specific sequences of MPV, and do not react with nucleic acids of other pathogens.

Solutions

Covid-19 Solution

SARS-CoV-2 Antigen Rapid Test

SARS-CoV-2 Antigen Rapid Qualitative Test Type B